Skip to main content
. 2024 Feb 7;49(6):716–731. doi: 10.1590/S1677-5538.IBJU.2023.0312

Table 2. Relevance of Enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT Parameters for Identification of Pathological Characteristics in ccRCC.

Pathological features Radiological parameters
Enhanced CT 68Ga-PSMA-11 PET/CT 18F-FDG PET/CT
CT value ICCa Pb value SUVmax ICCa Pc value SUVmax ICCa Pc value
Tumor necrosis 0.221 <0.001 0.119
Negative 128.97± 31.86 0.936 [0.895-0.961] 17.39 (7.58-25.20) 0.969 [0.949-0.982] 3.97 (2.98-6.40) 0.906 [0.848-0.943]
Positive 141.08±32.87 0.929 [0.787-0.961] 30.51 (26.18-32.54) 0.898 [0.679-0.968] 5.92 (3.32-6.81) 0.922 [0.767-0.975]
Sarcomatoid or rhabdoid feature 0.262 <0.001 0.038
Negative 129.86 32.66 0.937 [0.899-0.961] 18.76 (8.91-26.93) 0.971 [0.952-0.982] 4.02 (3.03-6.79) 0.907 [0.852-0.942]
Positive 145.33± 23.48 0.895 [0.477-0.984] 33.93 (32.54-35.33) 0.837 [0.195-0.976] 6.79 (5.45-8.04) 0.914 [0.537-0.987]
Adverse pathology * 0.179 <0.001 0.049
Negative 128.31±32.63 0.937 [0.894-0.962] 14.94 (7.36-23.32) 0.967 [0.944-0.981] 3.69 (2.94-6.40) 0.915 [0.859-0.949]
Positive 140.35± 29.63 0.927 [0.811-0.973] 31.55 (27.87-34.39) 0.869 [0.683-0.950] 5.59 (4.52-6.81) 0.900 [0.745-0.963]
*

Adverse pathology is defined as tumor presenting with necrosis or a sarcomatoid or rhabdoid feature

a

ICC: Data in the brackets are 95% confidence intervals

b

P values were calculated with Student's t test

c

P values were calculated with Mann-Whitney U test

ccRCC = clear-cell renal cell carcinoma; CT = computed tomography; ICC = Intraclass correlation coefficient; SUVmax = maximum standardized uptake value

Data are mean ± standard deviation for CT value, median (interquartile range) for SUVmax